Table 1 Characteristics of kidney transplant patient’s samples.

Group	Sample	Gender	Age	Ethnicity	Clinical Diagnosis	Calcineurin Inhibitors	BK Viruria	BK Viremia
BKV+	B3	M	59	Caucasian	T1DM	FK	Yes	Yes
	B4	M	59	Caucasian	T1DM	FK	Yes	Yes
	B5	M	76	African-American	T2DM	FK	Yes	Yes
	B6	M	76	African-American	T2DM	FK	Yes	Yes
	B7	M	31	Caucasian	PSGN	FK	Yes	Yes
	B8	M	31	Caucasian	PSGN	FK	Yes	Yes
	B9	M	47	Caucasian	PKD	CYA	Yes	Yes
	B10	M	59	Caucasian	HTN	FK	Yes	Yes
	B11	M	59	Caucasian	HTN	FK	Yes	Yes
	B12	M	65	Caucasian	HTN	FK	Yes	Yes
	B13	M	65	Caucasian	HTN	FK	Yes	Yes
	B15	M	66	Caucasian	T2DM	FK	Yes	Yes
BKV−	B16	M	52	African-American	HTN	CYA	No	No
	B17	F	62	African-American	T1DM	FK	No	No
	B18	F	40	Caucasian	Vasculitis	CYA	No	No
	B19	F	45	Asian	FSGS	CYA	No	No
	B20	M	51	Caucasian	T2DM	FK	No	No
	B21	M	41	Caucasian	HTN	FK	Yes	No
	B22	F	51	Caucasian	Lupus	FK	No	No
	B23	F	51	Caucasian	T1DM	CYA	Yes	No
	B24	F	46	Caucasian	RN	FK	Yes	No
	B25	M	54	Caucasian	HTN	FK	No	No
	B26	F	74	Caucasian	HTN	FK	No	No
	B27	M	46	Caucasian	HTN	FK	No	No
	B28	M	54	Caucasian	PKD	FK	No	No
	B29	F	32	Caucasian	T1DM	FK	Yes	No
	B30	M	68	Caucasian	Nephrocalcinosis	FK	No	No

Demographic data including sample number, gender, age, ethnicity, ESRD cause, calcineurin inhibitor agent. All patients received Thymoglobulin for induction and a calcineurin inhibitor along with mycophenolate and prednisone for maintenance. Samples were collected during the first 12 months post transplantation. T1DM (Type 1 Diabetes Mellitus); T2DM (Type 2 Diabetes Mellitus); HTN (Hypertension); FSGS (Focal Segmental Glomerulosclerosis); PSGN (Post Streptococcal Glomerulonephritis); PKD (Polycystic Kidney Disease); RN (Reflux Nephropathy).

Quick links

Search